Plain-English translation of NCT06216535 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a 26-week study testing whether , a medication typically used to treat depression and anxiety, can help reduce the number of severe asthma attacks in people with difficult-to-control asthma. Researchers believe that mood and stress may play a role in worsening asthma, so this medication might help by addressing both the emotional and physical sides of the condition. Half of the participants will receive the real medication, and half will receive a placebo (a pill with no active ingredient) to see if the treatment truly works.
People with severe, frequent asthma attacks can have a hard time finding relief even when they use the strongest inhaler medications. Researchers have noticed that stress, anxiety, and mood problems often go hand-in-hand with poorly controlled asthma, so this study explores whether treating the emotional side might also calm the physical symptoms.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic regularly over 26 weeks. You will take either the real medication or a placebo by mouth every day—starting at a low dose for two weeks, then increasing to the standard dose for 22 weeks, then tapering down at the end. Researchers will ask you to complete questionnaires about your asthma control, mood, and anxiety, and will measure biological markers (including blood samples and a breathing test) to understand how the medication works. You'll be monitored to make sure the treatment is safe and to track whether it reduces your asthma attacks.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States